Tri Gmnec 1 Tablet ER
Marketer
Capto Therapeutics
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Tri Gmnec 1 Tablet ER
Glycemia-Control ER (1 tablet) is a dual-action formulation managing blood glucose. This medication, used alongside diet and physical activity, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin use, consequently reducing blood sugar. Dosage and treatment duration for Glycemia-Control ER should strictly follow your physician's instructions. Administer with food to minimize gastrointestinal discomfort. For missed doses, take immediately unless the next dose is imminent; in this case, omit and resume the regular schedule. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping may increase hypoglycemia risk. Regular blood glucose monitoring is essential. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical advice before use. Kidney function will be assessed before treatment begins. Limit alcohol consumption to mitigate the potential for increased side effects.
Primary Ingredients of Tri Gmnec 1 Tablet ER
No information provided. A rewritten text cannot be provided.
Uses of Tri Gmnec 1 Tablet ER
Managing type 2 diabetes
Major Benefits of Tri Gmnec 1 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Tri Gmnec 1 Tablet ER with a meal.
Common Side effects of Tri Gmnec 1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Tri Gmnec 1 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Tri Gmnec 1 Tablet ER with a meal.
How Tri Gmnec 1 Tablet ER works:
Tri Gmnec 1 ER tablet combines glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions—to optimize blood glucose management when single or dual therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tri Gmnec 1 Tablet ER and alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tri Gmnec 1 mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Tri Gmnec 1mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with impaired kidney function should use Tri Gmnec 1 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Exercise caution when administering Tri Gmnec 1 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before use. Tri Gmnec 1 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Tri Gmnec 1 Tablet ER :
Should you forget a dose of Tri Gmnec 1 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tri Gmnec 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |



